about
The cost of implementing UK guidelines for the management of chronic kidney disease.Urinary ATP and visualization of intracellular bacteria: a superior diagnostic marker for recurrent UTI in renal transplant recipients?What is the real impact of acute kidney injury?Do acute elevations of serum creatinine in primary care engender an increased mortality risk?Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care?Engaging primary care in CKD initiatives: the UK experience.Kidney disease management in UK primary care: guidelines, incentives and information technology.Biological Variation of Plasma and Urinary Markers of Acute Kidney Injury in Patients with Chronic Kidney Disease.Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma.Referral patterns to renal services: what has changed in the past 4 years?The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.Acute kidney injury and critical limb ischaemia associated with the use of the so called "legal high" 3-fluorophenmetrazine.Coding errors in an analysis of the impact of pay-for-performance on the care for long-term cardiovascular disease: a case study.Older people remain on blood pressure agents despite being hypotensive resulting in increased mortality and hospital admission.External validation of the Berlin equations for estimation of GFR in the elderly.Chronic kidney disease management in the United Kingdom: NEOERICA project results.Late Low-Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral DensityEffect of Pay for Performance on Hypertension in the United KingdomIndividual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosisA UK general practice database study of prevalence and mortality of people with neural tube defectsContinuous ambulatory peritoneal dialysis. Experience in a single renal unit in the UKEndoluminal brushing of blocked permanent indwelling haemodialysis catheters saves moneyAutonomic neuropathy with B-cell lymphomaProgression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?The allogeneic T and B cell response is strongly dependent on complement components C3 and C4Individual kidney function before and after renal angioplastyPeritonitis in continuous ambulatory peritoneal dialysis due to Cylindrocarpon lichenicola infection'Flash pulmonary oedema' in a patient 24 years after aorto-renal vein graftHypotensive ischemic optic neuropathy and peritoneal dialysisAcute kidney injury and CKD: chicken or egg?Chronic kidney disease and life expectancySelf-management in chronic disease: clear benefits for blood pressure control in CKDChronic kidney disease: Psoriasis--a risk factor for chronic kidney disease?Association of kidney disease measures with poor outcomes
P50
Q33286782-F86560ED-904D-46C7-A7B2-55BF4900B4CBQ33619860-EAB61DBA-4976-428F-8194-375D783D57DBQ33838176-23C86447-C252-438D-B5A3-76C4F7669CB8Q34900872-AD5EEA09-8030-401A-8CE3-8D806D2DE817Q35552840-BAC76AA5-085B-4E6F-BA1E-80928FFC3ECAQ38056885-D4570BB0-253D-4218-96C8-5EEAA12BA5BCQ38573466-FD4E8975-2F64-4DBA-A113-6B5C6A9A2BC6Q39879335-32F20077-9867-4E7C-9509-8700A8534016Q43065292-9B366E6C-5E12-4440-A517-7F06CCE4F683Q43723254-76E764D1-13DA-4726-AC36-1EAF4E8C414CQ44462069-189ECCB7-D2D1-4335-8662-664664B5DDECQ45909997-3874C7EB-1D28-4C76-94FB-2E760D2FE54CQ46651602-057D1357-5B6C-4754-93EA-5529BC0B1FE3Q48029134-FFE86612-6F44-4DCD-B959-3E3DF7C37728Q51111677-E1360D54-3B09-4594-92C6-4AE1FDBAED81Q51917078-303871EB-8D7F-4702-B094-F31BD6F88C1AQ56974254-A8AE1637-A789-48FC-91F9-3EB9EC79F46CQ57250020-F3D80F22-66F3-473C-A444-ED9A9C200560Q73201689-9B95E14D-2725-4A58-9EEC-9726B58F49E5Q73324502-3542A549-6025-4D93-8E0F-B6729346373BQ73458294-9585309D-50E9-49D5-AB09-194444754D3AQ73719093-5B6A31D2-9E17-4445-87EF-1B3A67EEB01DQ74118141-B6A2351F-0C5C-41FB-B97A-BEDBBB6B413BQ74460691-B87E6585-9BC5-44BA-B98F-4EC8EACB2760Q74623666-6A8B9568-42C9-42FD-AE2C-A3BA578B1BE2Q74836086-349ACAE2-7B1A-47A0-B55A-6876501D2DD9Q77484705-A5AFC1C6-6813-43C5-8953-0F285C58D10BQ77799382-0357CFE9-D974-4BFD-8C0F-4EDF31AFAAD7Q78245103-016DD19D-781B-4589-97E3-09AD5CA5EA3FQ83737156-A08F1B81-C271-4C97-9987-BFAC18038E20Q84696545-07657BD1-8143-4908-BCC5-C28E89F6937DQ86800507-F1C5A35A-ADEE-4E9B-A50D-19986E554C28Q86843771-C8BAC4F6-1AD7-4C6E-8C81-0B5C6C0A69A6Q87381112-98060B06-C048-4384-9BD0-FADE154342E0
P50
description
researcher, ORCID id # 0000-0003-1736-8242
@en
wetenschapper
@nl
name
Christopher Farmer
@ast
Christopher Farmer
@en
Christopher Farmer
@es
Christopher Farmer
@nl
type
label
Christopher Farmer
@ast
Christopher Farmer
@en
Christopher Farmer
@es
Christopher Farmer
@nl
prefLabel
Christopher Farmer
@ast
Christopher Farmer
@en
Christopher Farmer
@es
Christopher Farmer
@nl
P106
P1153
57203031174
P21
P31
P496
0000-0003-1736-8242